Author:
Mitrofanova Alla,Fontanella Antonio M.,Burke George W.,Merscher Sandra,Fornoni Alessia
Abstract
Diabetes is the leading cause of chronic kidney disease worldwide. Despite the burden, the factors contributing to the development and progression of diabetic kidney disease (DKD) remain to be fully elucidated. In recent years, increasing evidence suggests that mitochondrial dysfunction is a pathological mediator in DKD as the kidney is a highly metabolic organ rich in mitochondria. Furthermore, low grade chronic inflammation also contributes to the progression of DKD, and several inflammatory biomarkers have been reported as prognostic markers to risk-stratify patients for disease progression and all-cause mortality. Interestingly, the term “sterile inflammation” appears to be used in the context of DKD describing the development of intracellular inflammation in the absence of bacterial or viral pathogens. Therefore, a link between mitochondrial dysfunction and inflammation in DKD exists and is a hot topic in both basic research and clinical investigations. This review summarizes how mitochondria contribute to sterile inflammation in renal cells in DKD.
Funder
American Society of Nephrology
Chernowitz Medical Research Foundation
Reference156 articles.
1. Chronic kidney disease: Global dimension and perspectives;Lancet,2013
2. USRDS (2021). 2021 USRDS Annual Data Report: Epidemiology of kidney disease in the United States.
3. Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO);Kidney Int.,2022
4. Skrabic, R., Kumric, M., Vrdoljak, J., Rusic, D., Skrabic, I., Vilovic, M., Martinovic, D., Duplancic, V., Ticinovic Kurir, T., and Bozic, J. (2022). SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice. Biomedicines, 10.
5. Immunogenic cell stress and death;Nat. Immunol.,2022
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献